OncoLize
PrivateLast Round
Seed
Apr 14, 2023
Total Funding Raised
$1.7M
Company Overview
OncoLize operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Seed round in April 2023.
OncoLize is a biopharmaceutical company that develops injectable drug depots for localized and controlled delivery of drugs inside tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoLize Comparables
Compare OncoLize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TargTex | 79% | |
| SURGE Therapeutics | 77% | |
| PolyPid | 71% |
For institutional investors. Book with your work email.
OncoLize Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OncoLize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2023
$1.7M round led by Libertatis Ergo Holding
For institutional investors. Book with your work email.
OncoLize Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoLize's valuation, stock price, and market status.
Is OncoLize a public or private company?
OncoLize is a private company.
What is the current stock price of OncoLize?
OncoLize is a private company, so its shares have no public market price. Caplight tracks OncoLize's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoLize worth (valuation)?
Valuation information for OncoLize is not publicly available.
Can I buy OncoLize stock?
OncoLize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoLize's last funding round?
OncoLize's most recent funding round was Seed on April 14, 2023.
Who are the main investors in OncoLize?
Key investors in OncoLize include Libertatis Ergo Holding.
Will OncoLize IPO soon?
No public IPO plans have been announced for OncoLize.
How can I track OncoLize secondary market activity?
Caplight tracks bids, offers, and trades in OncoLize's shares on secondary markets.